Objective: The prevalence of hepatitis B and hepatitis C in a sexually transmitted disease (STD) clinic population was studied, along with the prevalence of various STD agents, in an attempt to identify possible STD markers for the hepatitis C virus and help delineate the role of hepatitis C as an STD. The hepatitis C antibody rates found in the STD clinic were also compared with those found among patients attending a local OB/GYN clinic and those enrolled in a blood donor program, all from the same geographical area.
titis has now been attributed to non-A, non-B hepatitis worldwide. 1, 2 However, this type of transmission was recently estimated to account for as low as only 10-15% of patients with non-A, non-B hepatitis. 3 Recently, the isolation and cloning of a piece of DNA from non-A, non-B hepatitis virus and development of an assay for the antibody to hepatitis C virus (HCV) made possible the detection of many patients with a non-A, non-B hepatitis and the examination of transmission routes. 4'5 Recently, a 2nd-generation test for the detection of antibody vs. HCV was licensed. 6 This 2nd-generation test offers the advantage of increased sensitivity and specificity for the determination of HCV antibody.
s '6 Results have suggested that HCV is the major cause of transfusion-related non-A, non-B hepatitis, 7 especially in those cases that develop chronicity. 8 Additionally, HCV appears to be the major cause of a number of community-acquired non-A, non-B hepatitis for which no history of percutaneous exposure has been identified. 1, 2, 9 Studies investigating the possible sources of infection for non-A, non-B hepatitis or I-ICV without a history of percutaneous exposure have been contradictory to date. Several small case reports have been published recognizing possible transmission due to perinatal and conjugal relationships that follow patterns similar to transmission of hepatitis B, human immunodeficiency virus (HIV), and human T-lymphotropic virus type I (HTLV 1). 10, 11 In addition, other papers including studies relating HCV to patients with sexually transmitted diseases (STDs) 6'12 and to heterosexual activity with more than partner have been published. 13 Contrary to these findings, other investigations have suggested only rare sexual transmission of HCV among homosexuals 3 and among sexual contacts of high-risk intravenous (IV)-drug abusers. (Table 2) . 17 To determine whether the observed associations would hold up after con- Table 3 and by prevalence in Table 2 . The most prevalent risk factor was multiple sexual partners26 (17%), followed by sex with an IV-drug 
DISCUSSION
HCV has been shown to be the causative agent of the majority of cases of post-transfusion hepatitis, 1,20,) . especially high-risk transfusion patients such as hemophiliacs, [22] [23] [24] chronic renal patients, and those patients with recent cardiac surgery. 24 In addition, the agent has been found in U.S. veterans, 2s and implicated in maternal transmission, 11, 26 sexual transmission, 12, 13, 27 and IV-drug abuse. 28'29 The purpose of the present study was to explore the relationships between STDs and current or prior HCV infection and thus identify known STDs as possible markers for HCV. To discriminate the prevalence of HCV in the high-risk groups from that in the normal population, we studied the prevalence of I--ICV in 2 low-risk patient populations in the Harrisburg area.
Positive associations between STDs were found in the 150 STD patients studied. As expected, pa-tients positive for C. trachomatis were likely to be infected with N. gonorrhoeae. We also found hepatitis B virus (HBV) 
